Homebuilder PulteGroup's profit rises 9.9 pct
April 25 U.S. homebuilder PulteGroup Inc reported a 9.9 percent rise in quarterly profit, aided by higher home sales and average selling prices.
Dec 19 Catalyst Biosciences Inc :
* Catalyst Biosciences Inc - drug product fill-finish manufacturing services agreement for marzeptacog alfa (activated) for clinical trial applications
* Catalyst Biosciences Inc - has secured all rights to manufacturing process for Marzeptacog Alfa from Wyeth LLC, a wholly-owned subsidiary of Pfizer
* Catalyst Biosciences Inc - has signed a drug product fill-finish manufacturing services agreement with symbiosis pharmaceutical services limited
* Catalyst Biosciences Inc - prepared to initiate an efficacy study in 2017 for marzeptacog alpha (activated) Source text for Eikon: Further company coverage:
LAGOS, April 25 The Nigerian naira was quoted 18.3 percent weaker for portfolio investors on Tuesday compared with the interbank rate, a day after the central bank said it would allow investors to trade the currency at market determined rates.